Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety and Tolerability of SAR236553 (REGN727) in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid Modifying Therapy: A Randomized, Double-Blind, Placebo-Controlled Study

NCT01507831 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01507831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01507831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety and Tolerability of SAR236553 (REGN727) in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid Modifying Therapy: A Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
November 30, 2014
Enrollment
2,341 (actual)
Sites
320

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia